Galectin Therapeutics (GALT) Notes Payables (2024 - 2026)
Galectin Therapeutics (GALT) recorded Notes Payables of $33.04 million in Q2 2026.
Powered by 
Analysis
Galectin Therapeutics (GALT) Notes Payables (2024 - 2026) Analysis & Trends
At the end of FY2024, Galectin Therapeutics reported Notes Payables of $21.12 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn |
| 10 | Galectin Therapeutics | 222.99 Mn | 166.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.04 Mn |
| Sep 30, 2025 | 32.52 Mn |
| Mar 31, 2025 | 21.28 Mn |
| Dec 31, 2024 | 21.12 Mn |
| Sep 30, 2024 | 10.52 Mn |
API Access
Galectin Therapeutics Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();